AXIN1/MYC Axis Mediated the Osimertinib Resistance in EGFR Mutant Non-Small Cell Lung Cancer Cells

Tohoku J Exp Med. 2024 Jan 18. doi: 10.1620/tjem.2024.J002. Online ahead of print.NO ABSTRACTPMID:38233113 | DOI:10.1620/tjem.2024.J002

Source: The Tohoku Journal of Experimental Medicine - January 17, 2024 Category: Research Authors: Haoyue Yu Zhiguo Wang Yan Dong Li Li Xianming Fan Nan Zheng Ji Jiang Caiyu Lin Conghua Lu Kunlin Li Mingxia Feng Source Type: research